IN8bio
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell IN8bio and other ETFs, options, and stocks.About INAB
IN8bio, Inc. operates as a clinical stage biopharmaceutical company, which focuses on developing novel therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells. The company was founded by Lawrence S.
CEOWilliam T. Ho
CEOWilliam T. Ho
Employees18
Employees18
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2016
Founded2016
Employees18
Employees18
INAB Key Statistics
Market cap6.53M
Market cap6.53M
Price-Earnings ratio-0.23
Price-Earnings ratio-0.23
Dividend yield—
Dividend yield—
Average volume45.62K
Average volume45.62K
High today$1.51
High today$1.51
Low today$1.38
Low today$1.38
Open price$1.49
Open price$1.49
Volume51.07K
Volume51.07K
52 Week high$12.53
52 Week high$12.53
52 Week low$1.38
52 Week low$1.38
Stock Snapshot
As of today, IN8bio(INAB) shares are valued at $1.44. The company's market cap stands at 6.53M, with a P/E ratio of -0.23.
On 2025-12-17, IN8bio(INAB) stock traded between a low of $1.38 and a high of $1.51. Shares are currently priced at $1.44, which is +4.3% above the low and -4.6% below the high.
The IN8bio(INAB)'s current trading volume is 51.07K, compared to an average daily volume of 45.62K.
During the past year, IN8bio(INAB) stock moved between $1.38 at its lowest and $12.53 at its peak.
During the past year, IN8bio(INAB) stock moved between $1.38 at its lowest and $12.53 at its peak.
People also own
Based on the portfolios of people who own INAB. This list is generated using Robinhood data, and it’s not a recommendation.